Advertisement
Home Tags Health Costs

Tag: Health Costs

Participation in the Medicare Shared Savings Program is associated with an overall reduction in post-acute spending

Medicare Shared Savings Linked to Lower Post-Acute Spending

0
And, performance is similar on standardized costs for Oregon, Colorado Medicaid ACO models
Cardiovascular disease is increasing in the United States

AHA: CVD Expected to Cost U.S. $1.1 Trillion Per Year by 2035

0
American Heart Association estimates CVD-related disease in nearly half of Americans in <20 years
Lower intensity of peak daily energy expenditure estimated from ambulatory electrocardiographic monitoring is associated with increased health care utilization

Daily Energy Expenditure Linked to Health Care Utilization

0
Findings for energy expenditures estimated from ambulatory ECG monitoring
Nearly 6 percent of the world's health care spending is tied to smoking

Smoking Imposes Heavy Burden on Global Economy

0
Tobacco-related diseases caused 12 percent of deaths among smokers aged 30 to 69 in 2012
For patients with type 2 diabetes mellitus

Economic Benefit for Combo Statin/TG-Specific Tx in T2DM

0
Greatest cost reduction for statin/TG-specific-treated patients with TG level drop of ≥30 percent
For patients with newly diagnosed atrial fibrillation

Lower Inpatient Costs for Dabigatran, Rivaroxaban in A-Fib

0
Lower inpatient costs with dabigatran, rivaroxaban versus warfarin for newly diagnosed atrial fibrillation
Many doctors bill their private-paying patients two

Physician Excess Charges Create Financial Burden for Patients

0
Fees affect uninsured Americans, privately insured patients who use out-of-network physicians
The effect of price information varies for pediatric- and adult-focused clinicians

Effect of Providing Price Info Varies for Type of Clinician

0
No difference in rate at which orders were placed across study arms for pediatric-focused clinicians
Left ventricular assist devices improve quality of life in ambulatory patients with advanced heart failure

Left Ventricular Assist Device Ups QoL in Ambulatory Heart Failure

0
Left ventricular assist devices increase quality-adjusted life-years, readmissions, and costs
The excessive regulatory regime at the U.S. Food and Drug Administration is an important driver of high drug prices

Excessive FDA Regulation Driving High Drug Prices

0
First-in-class drugs are fast-tracked while follow-on drugs can take up to 15 years to be approved